Clinical Trial Intelligence for Biotech and Pharma Teams
Analyze trial landscapes, protocol patterns, endpoints, enrollment signals, sponsor behavior, recent registry changes, and historical AACT structure.
Decision questions
What this solution is built to answer.
What trial designs, endpoints, comparators, and enrollment patterns define this field?
Which sponsors are moving recently, and what changed in the registry?
Where are the enrollment, geography, eligibility, or endpoint risks?
How does trial activity alter competitive, valuation, or indication strategy?
Capabilities
What ARiDA can run for this use case.
ClinicalTrials.gov API research for live registry questions.
AACT SQL patterns for historical trial, sponsor, endpoint, and enrollment analysis.
Clinical trial pattern workflows for design comparison.
Recent change monitoring and scheduled background checks.
Downstream connection to valuation, competitive intelligence, and indication-expansion workflows.
Workflow table
Named workflows and expected artifacts.
| Workflow | Role | Artifacts |
|---|---|---|
| clinical-trials-research | Trial landscape and recent activity mapping | Trial evidence tables, sponsor maps, recent update notes |
| clinical-trial-patterns | Trial design pattern analysis | Endpoint, comparator, eligibility, enrollment, and design summaries |
| clinicaltrials-api-patterns | Live ClinicalTrials.gov API execution | Registry pulls, change summaries, structured trial outputs |
Evidence inputs
Data sources, tools, and user context.
Outputs
What the workflow should leave behind.
Deliverables
Trial landscape table with sponsor, status, phase, enrollment, endpoint, and geography fields.
Protocol-pattern brief for clinical strategy or diligence.
Recent registry-change memo with implications.
Structured inputs for valuation, CI, or indication expansion.
Proof points
Clinical trial work can route to live registry lookup or historical database analysis depending on recency and query shape.
AACT-specific patterns preserve the meaning of trial fields instead of relying on generic database guesses.
Trial outputs can feed valuation probability, competitive timing, and portfolio decisions.
FAQ
Common evaluation questions.
When should ARiDA use ClinicalTrials.gov API versus AACT?
Use the API for very recent registry state and change-sensitive work. Use AACT for historical, relational, and larger structured trial analysis.
Can trial evidence feed other workflows?
Yes. Trial evidence can feed competitive landscapes, valuation probabilities, regulatory briefs, and indication-expansion scoring.
Related solutions
Competitive Intelligence
Build competitive landscapes, TPP comparisons, patent-cliff views, market-share scenarios, and response plans from live web, trial, patent, literature, and database evidence.
Biotech Valuation
ARiDA runs evidence-backed biotech valuation workflows across single assets, multi-asset portfolios, platforms, fundraises, real options, Monte Carlo risk, and board dossiers.
Indication Expansion
Scan, assess, and sequence indication opportunities with scientific rationale, clinical feasibility, competitive density, IP context, market structure, and valuation logic.
Related reading
How to Monitor Very Recent Clinical Trial Changes
Good trial monitoring separates meaningful change from administrative churn and states what to do next.
How ARiDA Combines Live Web, Biomedical Databases, and Code Execution
Biotech research needs current signal, domain-native evidence, and computation in the same loop. Remove one layer and the output gets weaker.
How to Run a Competitive Landscape Deep Dive in One Workspace
A useful competitive landscape changes posture. Collection alone leaves the hard judgment unfinished.